Active ingredientEdrophonium ChlorideCat. No. P-E011-001CAS 116-38-1Family · Pharmaceutical analytical standards
Edrophonium
A very short-acting acetylcholinesterase inhibitor: from 1952, when Kermit Osserman and Lawrence Kaplan proposed it, it was used to diagnose myasthenia gravis, as well as to reverse neuromuscular block after surgery. This family brings together the active ingredient and labelled standards.
Did you know?The same test was also used for snake bites: if the paralysis improved with edrophonium, the antivenom was likely to work.
Go to the active ingredient →Active ingredientEdrophonium ChlorideCat. No. P-E011-001CAS 116-38-1
Isotopically labelledEdrophonium-d5 ChlorideCat. No. P-E011-003No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceEdrophonium chloride CRSEDQM code Y0001738Family EdrophoniumNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.